References
- Organization WH. Global Report on Diabetes: World Health Organization; 2016.
- Roglic G. WHO Global report on diabetes: A summary. International Journal of Noncommunicable Diseases. 2016; 1(1): 3. DOI: 10.4103/2468-8827.184853
- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010; 87(1): 4–14. DOI: 10.1016/j.diabres.2009.10.007
- Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice. 2011; 94(3): 311–21. DOI: 10.1016/j.diabres.2011.10.029
- Herman WH.
The Global Burden of Diabetes: An Overview. Diabetes Mellitus in Developing Countries and Underserved Communities . Springer. 2017; 1–5. DOI: 10.1007/978-3-319-41559-8_1 - Assah F, Mbanya JC.
Diabetes in Sub-Saharan Africa. Diabetes Mellitus in Developing Countries and Underserved Communities . Springer. 2017; 33–48. DOI: 10.1007/978-3-319-41559-8_3 - Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, et al. Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management. Diabetes/Metabolism Research and Reviews. 2011; 27(7): 639–53. DOI: 10.1002/dmrr.1239
- Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies:Uupdate on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010; 33(10): 2285–93. DOI: 10.2337/dc10-1303
- Balcıoğlu AS, Müderrisoğlu H. Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World Journal of Diabetes. 2015; 6(1): 80. DOI: 10.4239/wjd.v6.i1.80
- Pop-Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. Journal of Cardiovascular Translational Research. 2012; 5(4): 463–78. DOI: 10.1007/s12265-012-9367-6
- Ewing DJ, Clarke BF. Autonomic neuropathy: its diagnosis and prognosis. Clinics in Endocrinology and Metabolism. 1986; 15(4): 855–88. DOI: 10.1016/S0300-595X(86)80078-0
- Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985; 8(5): 491–8. DOI: 10.2337/diacare.8.5.491
- Valensi P, Paries J, Attali J, for Research FG. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications—the French multicenter study. Metabolism. 2003; 52(7): 815–20. DOI: 10.1016/S0026-0495(03)00095-7
- Ziegler D, Gries F, Mühlen H, Rathmann W, Spüler M, Lessmann F. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group C. Diabete & Metabolisme. 1993; 19(1 Pt 2): 143–51.
- Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes are. 2003; 26(5): 1553–79. DOI: 10.2337/diacare.26.5.1553
- Association AD. Physical activity/exercise and diabetes. Diabetes Care. 2004; 27(suppl 1): s58–s62. DOI: 10.2337/diacare.27.2007.S58
- Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care. 2003; 26(6): 1895–901. DOI: 10.2337/diacare.26.6.1895
- Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003; 26(6): 1895–901. DOI: 10.2337/diacare.26.6.1895
- Jin J, Wang W, Zhu L, Gu T, Niu Q, Li P, et al. Cardiovascular autonomic neuropathy is an independent risk factor for left ventricular diastolic dysfunction in patients with type 2 diabetes. BioMed Research International. 2017; 2017. DOI: 10.1155/2017/3270617
- Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J, Schabmann A. Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovascular Research. 1997; 34(1): 206–14. DOI: 10.1016/S0008-6363(97)00040-0
- Organization WH. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF consultation; 2006.
- Association AD. Standards of medical care in diabetes—2012. Diabetes Care. 2012; 35: S11. DOI: 10.2337/dc12-s011
- Chamberlain JJ, Rhinehart AS, Shaefer CF, Neuman A. Diagnosis and management of diabetes: Synopsis of the 2016 American diabetes association standards of medical care in diabetes. Annals of Internal Medicine. 2016; 164(8): 542–52. DOI: 10.7326/M15-3016
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL,
Jr , et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42(6): 1206–52. DOI: 10.1161/01.HYP.0000107251.49515.c2 - Health NIo. Classification of overweight and obesity by BMI, waist circumference, and associated disease risks; 2016.
- National CEPN. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002; 106(25): 3143. DOI: 10.1161/circ.106.25.3143
- Armstrong T, Bull F. Development of the world health organization global physical activity questionnaire (GPAQ). Journal of Public Health. 2006; 14(2): 66–70. DOI: 10.1007/s10389-006-0024-x
- Jeppsson J-O, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clinical Chemistry and Laboratory emdicine. 2002; 40(1): 78–89. DOI: 10.1515/CCLM.2002.016
- Ward D. Prolongation of the QT interval as an indicator of risk of a cardiac event. European Heart Journal. 1988; 9: 139–44. DOI: 10.1093/eurheartj/9.suppl_G.139
- Ahnve S. Correction of the QT interval for heart rate: Review of different formulas and the use of Bazett’s formula in myocardial infarction. American Heart Journal. 1985; 109(3): 568–74. DOI: 10.1016/0002-8703(85)90564-2
- Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: A statement by the American diabetes association. Diabetes Care. 2005; 28(4): 956–62. DOI: 10.2337/diacare.28.4.956
- Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nature Reviews Endocrinology. 2012; 8(7): 405. DOI: 10.1038/nrendo.2012.21
- Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M. Diagnosis and management of diabetic autonomic neuropathy. British Medical Journal (Clinical Research Ed). 1983; 287(6384): 61. DOI: 10.1136/bmj.287.6384.61-a
- Jung C-H, Kim B-Y, Kim C-H, Kang S-K, Jung S-H, Mok J-O. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients. Cardiovascular Diabetology. 2012; 11(1): 24. DOI: 10.1186/1475-2840-11-24
- Jyotsna VP, Singh AK, Deepak K, Sreenivas V. Progression of cardiac autonomic dysfunction in newly detected type 2 diabetes. Diabetes Research and Clinical Practice. 2010; 90(1): e5–e6. DOI: 10.1016/j.diabres.2010.04.009
- Khandelwal E, Jaryal AK, Deepak KK. Pattern and prevalence of cardiovascular autonomic neuropathy in diabetics visiting a tertiary care referral center in India. Indian J Physiol Pharmacol. 2011; 55(2): 119–27.
- Pappachan J, Sebastian J, Bino B, Jayaprakash K, Vijayakumar K, Sujathan P, et al. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgraduate Medical Journal. 2008; 84(990): 205–10. DOI: 10.1136/pgmj.2007.064048
- Gandhi AU, Patel HP, Patel SV, Kadam AY, Parmar VM. Cardiac autonomic neuropathy in relation to cardiovascular reflex tests and QTc prolongation in diabetes mellitus. National Journal of Integrated Research in Medicine. 2017; 8(4).
- Eze C, Onwuekwe I, Ogunniyi A. The frequency and pattern of cardiac autonomic neuropathy (CAN) in type 2 DM patients in a diabetic clinic in Enugu south-east Nigeria. Niger J Med. 2013; 22(1): 24–31.
- Jaiswal M, Divers J, Urbina EM, Dabelea D, Bell RA, Pettitt DJ, et al. Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for diabetes in youth cohort study. Pediatric Diabetes. 2018; 19(4): 680–9. DOI: 10.1111/pedi.12633
- Ratzmann KP, Raschke M, Gander I, Schimke E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. Journal of Diabetic Complications. 1991; 5(1): 1–5. DOI: 10.1016/0891-6632(91)90002-7
- Zoppini G, Cacciatori V, Raimondo D, Gemma M, Trombetta M, Dauriz M, et al. The prevalence of cardiovascular autonomic neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study (VNDS). Diabetes Care. 2015:
dc150081 . DOI: 10.2337/dc15-0081 - Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries F. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabetic Medicine. 1992; 9(9): 806–14. DOI: 10.1111/j.1464-5491.1992.tb01898.x
- American Diabetes Association. Standards of edical care in diabetes—2016. Diabetes Care. 2016; 39: 39–46. DOI: 10.2337/dc16-S003
- Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. Journal of Diabetes Investigation. 2013; 4(1): 4–18. DOI: 10.1111/jdi.12042
- Rolim LCdSP, Sá JRd, Chacra AR, Dib SA. Diabetic cardiovascular autonomic neuropathy: risk factors, clinical impact and early diagnosis. Arquivos Brasileiros de Cardiologia. 2008; 90(4): e24–e32. DOI: 10.1590/S0066-782X2008000400014
- Fisher VL, Tahrani AA. Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Ttherapy. 2017; 10: 419. DOI: 10.2147/DMSO.S129797
- Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007; 115(3): 387–97. DOI: 10.1161/CIRCULATIONAHA.106.634949
- Refaie W. Assessment of cardiac autonomic neuropathy in long standing type 2 diabetic women. The Egyptian Heart Journal. 2014; 66(1): 63–9. DOI: 10.1016/j.ehj.2013.06.002
- Ko S-H, Park S-A, Cho J-H, Song K-H, Yoon K-H, Cha B-Y, et al. Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: A 7-year follow-up study. Diabetes Care. 2008; 31(9): 1832–6. DOI: 10.2337/dc08-0682
- Huang C-C, Lee J-J, Lin T-K, Tsai N-W, Huang C-R, Chen S-F, et al. Diabetic retinopathy is strongly predictive of cardiovascular autonomic neuropathy in type 2 diabetes. Journal of diabetes research. 2016; 2016. DOI: 10.1155/2016/6090749
- Krolewski AS, Barzilay J, Warram JH, Martin BC, Pfeifer M, Rand LI. Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy. Diabetes. 1992; 41(4): 430–7. DOI: 10.2337/diab.41.4.430
- Pavy-Le Traon A, Fontaine S, Tap G, Guidolin B, Senard J-M, Hanaire H. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clinical Autonomic Research. 2010; 20(3): 153–60. DOI: 10.1007/s10286-010-0062-x
- Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World Journal of Diabetes. 2014; 5(1): 17. DOI: 10.4239/wjd.v5.i1.17
- Feldman EL, Nave K-A, Jensen TS, Bennett DL. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 2017; 93(6): 1296–313. DOI: 10.1016/j.neuron.2017.02.005
- Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy. Current Pharmaceutical Design. 2008; 14(10): 953–61. DOI: 10.2174/138161208784139774
- Larsen JR, Sjøholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, et al. Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes. Diabetes Care. 2004; 27(4): 963–6. DOI: 10.2337/diacare.27.4.963
- Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002; 25(7): 1135–41. DOI: 10.2337/diacare.25.7.1135
- Witte D, Tesfaye S, Chaturvedi N, Eaton S, Kempler P, Fuller J, et al. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005; 48(1): 164–71. DOI: 10.1007/s00125-004-1617-y
- O’Brien I, O’Hare P, Corrall R. Heart rate variability in healthy subjects: Effect of age and the derivation of normal ranges for tests of autonomic function. Heart. 1986; 55(4): 348–54. DOI: 10.1136/hrt.55.4.348
- Esler M, Hastings J, Lambert G, Kaye D, Jennings G, Seals DR. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2002; 282(3): R909–R16. DOI: 10.1152/ajpregu.00335.2001
- Ewing D, Campbell I, Murray A, Neilson J, Clarke B. Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J. 1978; 1(6106): 145–7. DOI: 10.1136/bmj.1.6106.145
- Rowe JW, Troen BR. Sympathetic nervous system and aging in man. Endocrine Reviews. 1980; 1(2): 167–79. DOI: 10.1210/edrv-1-2-167
- Bonnemeier H, Wiegand UK, Brandes A, Kluge N, Katus HA, Richardt G, et al. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. Journal of Cardiovascular Electrophysiology. 2003; 14(8): 791–9. DOI: 10.1046/j.1540-8167.2003.03078.x
- Valensi PE, Johnson NB, Maison-Blanche P, Extramania F, Motte G, Coumel P. Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients. Diabetes Care. 2002; 25(5): 918–23. DOI: 10.2337/diacare.25.5.918
- Ninkovic VM, Ninkovic SM, Miloradovic V, Stanojevic D, Babic M, Giga V, et al. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes. Acta Diabetologica. 2016; 53(5): 737–44. DOI: 10.1007/s00592-016-0864-y
- Vinik AI, Casellini C, Parson HK, Colberg SR, Nevoret M-L. Cardiac autonomic neuropathy in diabetes: A predictor of cardiometabolic events. Frontiers in Neuroscience. 2018; 12. DOI: 10.3389/fnins.2018.00591